1. Home
  2. MPTI vs ACIU Comparison

MPTI vs ACIU Comparison

Compare MPTI & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo M-tron Industries Inc.

MPTI

M-tron Industries Inc.

HOLD

Current Price

$92.59

Market Cap

350.9M

Sector

N/A

ML Signal

HOLD

Logo AC Immune SA

ACIU

AC Immune SA

HOLD

Current Price

$2.46

Market Cap

288.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MPTI
ACIU
Founded
1965
2003
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
350.9M
288.0M
IPO Year
2022
2015

Fundamental Metrics

Financial Performance
Metric
MPTI
ACIU
Price
$92.59
$2.46
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$71.00
$10.00
AVG Volume (30 Days)
56.4K
246.7K
Earning Date
05-08-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.67
N/A
Revenue
$54,417,000.00
N/A
Revenue This Year
$11.06
$706.75
Revenue Next Year
$12.15
$321.13
P/E Ratio
$135.36
N/A
Revenue Growth
11.03
N/A
52 Week Low
$36.38
$1.60
52 Week High
$90.69
$4.00

Technical Indicators

Market Signals
Indicator
MPTI
ACIU
Relative Strength Index (RSI) 75.58 31.11
Support Level $60.13 $2.03
Resistance Level N/A $3.13
Average True Range (ATR) 4.19 0.17
MACD 1.14 -0.03
Stochastic Oscillator 91.48 3.45

Price Performance

Historical Comparison
MPTI
ACIU

About MPTI M-tron Industries Inc.

M-Tron Industries Inc is an electronic components manufacturer based in the United States. Along with its subsidiaries, the company is engaged in designing, manufacturing, and marketing high-engineered, high-reliability frequency and spectrum control products used to control the frequency or timing of signals in electronic circuits in various applications. The company serves markets in aerospace and defense, space, and avionics sectors. Its product offerings include microwave and millimeter-wave filters, crystal resonators, clock oscillators, voltage-controlled crystal oscillators, low noise amplifiers, couplers, attenuators, and switches, among others. Geographically, it derives maximum revenue from the domestic market, and the rest from Malaysia, Australia, Greece, and other countries.

About ACIU AC Immune SA

AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

Share on Social Networks: